The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
This article has been corrected | View Correction

Abstract

Objective:

Previous studies suggest that prenatal immune challenges may elevate the risk of schizophrenia and related psychoses in offspring, yet there has been limited research focused on maternal bacterial infection. The authors hypothesized that maternal bacterial infection during pregnancy increases offspring risk of psychotic disorders in adulthood, and that the magnitude of this association varies as a function of severity of infectious exposure and offspring sex.

Methods:

The authors analyzed prospectively collected data from 15,421 pregnancies among women enrolled between 1959 and 1966 at two study sites through the Collaborative Perinatal Project. The sample included 116 offspring with confirmed psychotic disorders. The authors estimated associations between maternal bacterial infection during pregnancy and psychosis risk over the subsequent 40 years, stratified by offspring sex and presence of reported parental mental illness, with adjustment for covariates.

Results:

Maternal bacterial infection during pregnancy was strongly associated with psychosis in offspring (adjusted odds ratio=1.8, 95% CI=1.2–2.7) and varied by severity of infection and offspring sex. The effect of multisystemic bacterial infection (adjusted odds ratio=2.9, 95% CI=1.3–5.9) was nearly twice that of less severe localized bacterial infection (adjusted odds ratio=1.6, 95% CI=1.1–2.3). Males were significantly more likely than females to develop psychosis after maternal exposure to any bacterial infection during pregnancy.

Conclusions:

The study findings suggest that maternal bacterial infection during pregnancy is associated with an elevated risk for psychotic disorders in offspring and that the association varies by infection severity and offspring sex. These findings call for additional investigation and, if the findings are replicated, public health and clinical efforts that focus on preventing and managing bacterial infection in pregnant women.

Epidemiological and preclinical studies have identified maternal viral infection during pregnancy as a putative risk factor for schizophrenia (1). However, there is a relative paucity of research on bacterial infection (24). Bacterial infections—such as urinary tract infection and bacterial vaginosis—are highly prevalent as a result of physiological changes and immune suppression during pregnancy (5). Often asymptomatic, bacterial infections are largely overlooked and left untreated in antenatal care settings. However, such infections can pose a significant threat to pregnancy and healthy fetal development (6, 7), and untreated infections have been associated with severe neurodevelopmental disorders in offspring (8, 9).

Despite considerable evidence on the immediate impact of gestational bacterial infection on perinatal health, long-term neuropsychiatric consequences remain unclear. There have been only two previous prospective cohort studies that specifically investigated bacterial infection in relation to offspring risk for psychotic disorders. One study reported that maternal sinusitis, tonsillitis, pneumonia, cystitis, pyelonephritis, or bacterial venereal infection was associated with more than a twofold increase in schizophrenia risk (2). This finding was replicated in another study specific to pyelonephritis (10). We previously reported that maternal immune dysregulation in general was associated with a significantly higher risk of offspring psychotic disorders (11, 12), although this was not specifically tied to bacterial infection.

Animal studies have provided robust experimental evidence on how maternal bacterial infection during pregnancy may cause lasting changes in the structure and function of the fetal brain (13, 14). For example, murine embryos exposed to bacterial peptidoglycan (a key component of the bacterial cell wall) exhibited abnormal proliferation of neuronal precursor cells, permanently altering their brain architecture (15). After birth, exposed offspring displayed behavioral, neurochemical, and neurophysiological abnormalities consistent with observations in people with psychotic illness (15). Taken together, these experimental studies provide a strong rationale for testing the hypothesis that maternal bacterial infection during pregnancy disrupts fetal neurodevelopment, consistent with subsequent risk for psychotic disorders, using epidemiological samples. Thus, we hypothesized that maternal bacterial infection during pregnancy increases offspring risk of psychotic disorders in adulthood, and that the magnitude of this association varies as a function of severity of infectious exposure.

Earlier studies, including by our group, reported associations between gestational immune disruption and heightened risk of psychotic disorders among males to a greater extent than females (12, 1618). To replicate these findings, we hypothesized that the effect of maternal bacterial infection during pregnancy on the risk of psychotic disorders would be greater among male than female offspring. In addition to sex differences, numerous studies have reported on strong heritability of psychotic illnesses (19), with a substantial overlap with other psychiatric disorders (20). In fact, previous studies have demonstrated the utility of family history as a proxy for genetic liability (19, 21), and one study specifically investigated synergistic effects of familial liability to psychosis and prenatal bacterial infection on subsequent risk for schizophrenia (10). These findings were substantiated by a more recent study finding that the impact of parental history of mental disorder was not confined to concordant parental mental disorders but rather that offspring are at increased risk of a wide range of mental disorders (20). Given these findings taken together, we hypothesized that the association between maternal bacterial infection during pregnancy and psychosis risk would be greater among offspring with a parental history of mental illness than among those without.

Methods

Study Population

There were 16,188 live births enrolled between 1959 and 1966 at the Boston and Providence sites of the Collaborative Perinatal Project (CPP), currently known as the New England Family Study (NEFS). The CPP was initiated to investigate prospectively the prenatal and familial antecedents of pediatric, neurological, and psychological disorders of childhood (22). Details of the CPP and NEFS methodology have been reported elsewhere (11, 2326). As shown in Figure 1, we excluded offspring who did not survive to the period of risk for psychosis (N=467), those who had entirely missing records for infectious disease during their mothers’ pregnancy (N=44), and those whose mothers had infection of unknown etiology during pregnancy (N=156). In a series of previous follow-up studies of the NEFS participants, we identified those with psychotic disorders among the original parents and among the offspring, who are now adults in their 50s (11, 2326). To minimize false positive cases of psychotic disorders in offspring, we further excluded those who had a treatment history for organic or substance-induced psychosis (N=100). The final analytic sample included a total of 15,421 participants.

FIGURE 1.

FIGURE 1. Selection of the analytic sample from the New England cohorts of the Collaborative Perinatal Project

Collection and Processing of the Exposure Data

Collection of the exposure data was jointly conducted by trained nonphysician interviewers and physicians, beginning at the time of registration for prenatal care, at intervals of 4 weeks during the first 7 months of pregnancy, every 2 weeks at 8 months, and every week thereafter, using standardized protocols, forms, manuals, and codes (26). Throughout the initial and repeat prenatal visits, interviewers collected reproductive and gynecological history, recent and past medical history, and family health and genetic history. They also conducted infectious disease and system review at the initial visit or as soon thereafter as possible. Physicians reviewed the data collected by the interviewer, collected further details on past and recent medical history, completed initial prenatal examination and observations, and recorded the date and listed any diagnoses unrelated to prenatal care that came to their attention. Medical and lay editing was subsequently carried out in conjunction with the participant’s complete hospital records by the obstetric coordinator or a board-certified obstetrician. Lastly, each participant’s study record and complete hospital records were summarized no later than 6 months after delivery.

Ascertainment of Exposure Status

The primary exposure variable included any bacterial infections that occurred during pregnancy, defined as the period between the estimated date of conception and the end of the third stage of labor. If women had more than one infection, they were counted only once using the Boolean OR operator. Infections that affected more than one major organ system were defined as multisystemic infections (e.g., sepsis), whereas those specifically affecting one system (e.g., vaginitis) were defined as localized infections. A total of 399 multisystemic and 3,201 localized infections during pregnancy were recorded. Localized bacterial infections included tuberculosis (N=8), pneumonia (N=83), syphilis (N=66), gonorrhea (N=15), kidney, ureter, and bladder infection (N=1,203), and vaginitis (N=2,136).

Assessment of Offspring With Schizophrenia and Related Psychoses

Cohort members with psychosis were identified between the ages of 32 and 39 through a systematic follow-up of the entire New England cohorts of the CPP from 1997 to 2003. The parents and offspring with a history of psychiatric hospitalization and/or possible psychotic or bipolar illness were identified from the following sources: record linkages with public hospitals, mental health clinics, and the Massachusetts and Rhode Island Departments of Mental Health; several follow-up and case-control studies nested within the larger New England cohort involving direct interviews; and reports from participants in these interview studies of family members with a history of psychotic or bipolar symptoms or diagnoses. Adult offspring in the New England cohorts with major psychotic disorders were identified through a two-stage diagnostic assessment procedure from 1996 to 2007, approximately 30 years after and blind to prior assessments. In stage 1, 249 individuals with possible psychotic illness were identified through systematic follow-up and subsequently diagnosed through administration of the Structured Clinical Interview for DSM-IV Axis I Disorders (27) (N=173) or review of medical charts alone (N=76). Based on interview data and medical record review, trained Ph.D.- and M.D.-level diagnosticians then made best-estimate consensus diagnoses according to DSM-IV criteria for lifetime prevalence of psychotic and other psychiatric disorders (28). A total of 116 adult offspring were found to have a nonorganic psychotic disorder, including schizophrenia disorders (N=52; schizophrenia and schizoaffective disorder, depressive type), affective psychoses (N=53; schizoaffective disorder, bipolar type, bipolar disorder with psychotic features, and major depressive disorder with psychotic features), and other nonaffective psychoses (N=11; delusional disorder, brief psychosis, and nonaffective psychoses, type not specified) (11). Approval for the study was granted by institutional review boards at Harvard University, Brown University, and local psychiatric facilities. Written consent was obtained from all interviewed subjects, and they were compensated for their participation.

Covariates

Covariates included maternal race/ethnicity, study site, years of maternal education, parental socioeconomic index, and year and season of birth. A socioeconomic index, which was adapted from the Bureau of the Census and derived from the education and occupation of the head of household along with household income, was assigned to each pregnant woman; this continuous measure was later categorized in quartiles (29). We further adjusted for reported parental history of mental illness (when we did not test for its effect modification) as a known risk factor for schizophrenia (20) that has also been found to be associated with infections (30). Previously, our group reported that the psychiatric history of both parents may independently predict offspring’s risk for psychotic disorders (31). In this study, we operationalized genetic susceptibility to psychiatric disorder by aggregating the information collected from the mothers about their own as well as their spouse’s history of nervous problems requiring hospitalization, psychiatric treatment, or other therapy (i.e., clinically significant nervous problems) at two time points: during pregnancy and at the offspring’s age 7 visit. The overall rate of reported parental history of mental illness was 11%. Additionally, we adjusted for maternal exposure to viral infection during pregnancy to address potential confounding by concomitant viral infection. Lastly, we controlled for the offspring’s participation in the final follow-up of the larger CPP study—conducted at offspring age 7—given its observed association with the likelihood of being identified as a psychosis case subject in adulthood.

Statistical Analyses

We used chi-square and t tests (two-sided) to compare the demographic and perinatal characteristics of the exposed and unexposed mothers, and of the psychosis case subjects and non-case subjects. Logistic regression analyses were used to estimate odds ratios of psychoses for maternal exposure to any bacterial infections and to localized bacterial infections during pregnancy. Logistic regression models were adjusted for maternal neurological or psychiatric conditions during pregnancy, maternal education, parental socioeconomic index, maternal race/ethnicity, study site, season and year of birth, parental history of mental illness, offspring participation in the final follow-up of the larger CPP study, and concomitant viral infection during pregnancy. Exact logistic regression analyses were used to estimate the effects of multisystemic bacterial infection given the small number of case subjects exposed to this type of infection. In these models, we could only adjust for a few covariates that are reported to be key confounders in the hypothesized relationship and had strong statistical associations with both the exposure and the outcome in the analytic sample. Lastly, we examined effect modification of the hypothesized associations by offspring sex alone and presence of parental mental illness alone, using the Wald statistic. All analyses were conducted using SAS, version 9.4 (SAS Institute, Cary, N.C.).

Sensitivity Analyses

Given that instances of maternal bacterial infection during pregnancy were not all serologically confirmed, some may have been misclassified (i.e., false positive). If a reported instance of bacterial infection was accompanied by any antibacterial treatment (e.g., chloramphenicol, erythromycin, nitrofurantoin, penicillin, streptomycin, tetracycline) and/or a physician’s diagnosis, we defined this as confirmed and conducted analyses considering only confirmed instances of bacterial infection. We assessed the robustness of our findings to potential misclassification of exposure by replicating the main effects with the confirmed instances of bacterial infection.

Results

Mothers who had bacterial infections during pregnancy were more likely to be nonwhite, unmarried, younger, and less educated; to have lower socioeconomic status; to reside in Providence; to have neurological or psychiatric conditions during pregnancy; and to report a history or a spouse’s history of clinically significant nervous problems, compared with mothers who had no bacterial infection during pregnancy (see Table 1).

TABLE 1. Descriptive statistics for the analytical sample (N=15,421), by exposure to maternal bacterial infection during pregnancya

CharacteristicExposedUnexposed
N%N%p
Total3,49922.711,92277.3
Offspring sex0.52
 Male1,75522.36,10177.7
 Female1,74323.05,81977.0
Maternal race/ethnicity<0.0001
 White2,93122.010,36578.0
 Nonwhite56826.71,55773.3
Maternal marital status<0.0001
 Married3,01521.910,75578.1
 Unmarried48429.41,16570.6
Maternal neurological or psychiatric conditions during pregnancyb<0.0001
 Present61928.71,54171.3
 Not present2,85923.79,19776.3
Parental history of mental illness<0.0001
 Present48027.51,26672.5
 Not present2,96422.110,41077.9
Season of birth0.92
 Spring85622.62,92777.4
 Summer, fall, or winter2,95522.78,99577.3
Study site0.0012
 Boston2,57622.19,09677.9
 Providence92324.62,82675.4
Participation in the final follow-up of the Collaborative Perinatal Project study0.44
 Yes2,71422.89,17377.2
 No78522.22,74977.8
Socioeconomic index<0.0001
 1st quartile (lowest)1,03325.43,02774.6
 2nd quartile96723.73,08976.3
 3rd quartile73121.72,63578.3
 4th quartile (highest)67019.92,69780.1
Viral infection during pregnancy0.10
 Present23824.872175.2
 Not present3,29122.611,20177.4
MeanSDMeanSDp
Maternal age (years)24.95.925.25.90.017
Maternal education (years)11.12.511.42.5<0.0001
Year of birth1962.81.91962.61.9<0.0001

aNumber and proportion of missing observations: offspring sex, N=3 (0.02%); maternal marital status, N=2 (0.02%); maternal neurological or psychiatric conditions during pregnancy, N=1,205 (7.8%); parental history of mental illness, N=310 (2.0%); socioeconomic index, N=584 (3.8%); year of birth, N=7 (0.05%). We created a separate category for these missing data and ensured that they were included in the analytic sample.

bMaternal neurological or psychiatric conditions during pregnancy included convulsive disorder (not eclamptic), convulsions (not eclamptic), mental retardation, organic brain disease, psychosis/neurosis, other neurological or neuromuscular disease (including brain surgery), drug habituation/addiction, and alcoholism.

TABLE 1. Descriptive statistics for the analytical sample (N=15,421), by exposure to maternal bacterial infection during pregnancya

Enlarge table

When examined with respect to psychosis status in adulthood, offspring case subjects were more likely to have at least one parent with a clinically significant mental illness and to have participated in the study’s age 7 assessment than non-case subjects (see Table 2). Mothers of case subjects were more likely to be nonwhite, reside in Providence, have neurological or psychiatric conditions during pregnancy, and be less educated than mothers of non-case subjects.

TABLE 2. Descriptive statistics for the analytical sample (N=15,421), by clinical diagnosis of adult psychosis in offspringa

CharacteristicPsychosisNo Psychosis
N%N%p
Total1160.815,30599.2
Offspring sex0.25
 Male680.97,78899.1
 Female480.67,51499.4
Maternal race/ethnicity0.0029
 White890.713,20799.3
 Nonwhite271.32,09898.7
Maternal marital status0.98
 Married1040.813,66699.2
 Unmarried120.71,63799.3
Maternal neurological or psychiatric conditions during pregnancyb0.017
 Present261.22,13498.8
 Not present850.711,97199.3
Parental history of mental illness<0.001
 Present271.61,71998.4
 Not present880.713,27799.3
Season of birth0.75
 Spring270.73,75699.3
 Summer, fall, or winter890.811,54999.2
Study site0.033
 Boston780.711,59499.3
 Providence381.03,71199.0
Participation in the final follow-up of the Collaborative Perinatal Project study0.010
 Yes1010.911,78699.1
 No150.43,51999.6
Socioeconomic index0.063
 1st quartile (lowest)330.84,02799.2
 2nd quartile370.94,00999.1
 3rd quartile300.93,33699.1
 4th quartile (highest)140.43,35199.6
Viral infection during pregnancy0.93
 Present70.795299.3
 Not present1090.814,35399.2
MeanSDMeanSDp
Maternal age (years)25.25.925.15.90.83
Maternal education (years)10.72.011.42.50.0029
Year of birth1962.42.01962.71.90.10

aNumber and proportion of missing observations: offspring sex, N=3 (0.02%); maternal marital status, N=2 (0.02%); maternal neurological or psychiatric conditions during pregnancy, N=1,205 (7.8%); parental history of mental illness, N=310 (2.0%); socioeconomic index, N=584 (3.8%); year of birth, N=7 (0.05%). We created a separate category for these missing data and ensured that they were included in the analytic sample.

bMaternal neurological or psychiatric conditions during pregnancy included convulsive disorder (not eclamptic), convulsions (not eclamptic), mental retardation, organic brain disease, psychosis/neurosis, other neurological or neuromuscular disease (including brain surgery), drug habituation/addiction, and alcoholism.

TABLE 2. Descriptive statistics for the analytical sample (N=15,421), by clinical diagnosis of adult psychosis in offspringa

Enlarge table

Main Results

Of 15,421 cohort mothers in the analytic sample, 3,499 (23%) had bacterial infection; of these, 3,191 (21%) had localized infections, 399 (3%) had multisystemic infections, and 91 (<1%) had both. As shown in Table 3, maternal bacterial infection during pregnancy was significantly associated with psychotic illnesses among adult offspring (adjusted odds ratio=1.8, 95% CI=1.2–2.7). Multisystemic bacterial infection was more strongly associated with offspring development of psychosis (adjusted odds ratio=2.9, 95% CI=1.3–5.9) than localized bacterial infection (adjusted odds ratio=1.6, 95% CI=1.1–2.3).

TABLE 3. Associations between maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood

Unadjusted AnalysisAdjusted Analysis
Exposure TypeOffspring Psychosis (N)Odds Ratio95% CIpOdds Ratio95% CIp
Any bacterial infection432.01.4–3.0<0.0011.8a1.2–2.70.002
Localized bacterial infection361.71.1–2.50.0121.6a1.1–2.30.027
Multisystemic bacterial infection93.2b1.4–6.40.0062.9b,c1.3–5.90.011

aOdds ratios were adjusted for maternal education, socioeconomic index, maternal race/ethnicity, maternal neurological or psychiatric conditions during pregnancy, study site, season and year of birth, offspring sex, parental history of mental illness, participation in the final follow-up of the Collaborative Perinatal Project study, and viral infection during pregnancy, through multivariate logistic regression models.

bWe fitted exact logistic regression for multisystemic bacterial infection and estimated exact p values.

cOdds ratio was adjusted for viral infection during pregnancy, parental history of mental illness, and maternal race/ethnicity.

TABLE 3. Associations between maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood

Enlarge table

As shown in Table 4, the association between prenatal exposure to any bacterial infection and subsequent psychosis was significantly modified by offspring sex. Male offspring were nearly three times as likely to develop a psychotic disorder after maternal bacterial infection during pregnancy, whereas female offspring showed no difference in the likelihood by the exposure status (males: adjusted odds ratio=2.6, 95% CI=1.6–4.2; females: adjusted odds ratio=1.0, 95% CI=0.5–1.9; p=0.018). Similarly, males were more than twice as likely to develop a psychotic disorder compared with females after maternal exposure to localized bacterial infection (males: adjusted odds ratio=2.1, 95% CI=1.2–3.4; females: adjusted odds ratio=1.0, 95% CI=0.5–1.9; p=0.084). Since there was only one female case subject exposed to multisystemic maternal bacterial infection, we reported results specific to males without evaluating statistical significance of effect modification. Males who were prenatally exposed to multisystemic infection had five times the odds of developing a psychotic disorder relative to unexposed males (adjusted odds ratio=5.0, 95% CI=2.0–10.7).

TABLE 4. Stratified analyses of maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood, by offspring sex

Unadjusted AnalysisAdjusted Analysis
Exposure Type and Offspring SexOffspring Psychosis (N)Odds Ratio95% CIpOdds Ratio95% CIp
Any bacterial infection
 Male312.91.8–4.80.0192.6a1.6–4.20.018
 Female121.10.6–2.11.0a0.5–1.9
Localized bacterial infection
 Male252.21.4–3.70.0852.1a1.2–3.40.084
 Female111.10.5–2.11.0a0.5–1.9
Multisystemic bacterial infection
 Male85.3b2.2–11.35.0b,c2.0–10.7
 Female1

aOdds ratios were adjusted for maternal education, socioeconomic index, maternal race/ethnicity, study site, season and year of birth, parental history of mental illness, participation in the final follow-up of the Collaborative Perinatal Project study, maternal neurological or psychiatric conditions during pregnancy, and viral infection during pregnancy, through multivariate logistic regression models.

bWe fitted exact logistic regression for male participants given the limited number of female case subjects exposed to multisystemic bacterial infection. Accordingly, the interaction term was not tested for statistical significance for this type of bacterial infection.

cOdds ratios and confidence intervals were adjusted for viral infection during pregnancy, parental mental illness, and maternal race/ethnicity.

TABLE 4. Stratified analyses of maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood, by offspring sex

Enlarge table

As shown in Table 5, we observed a somewhat greater magnitude of hypothesized associations among offspring with reported parental mental illness compared with those without, but with no statistical support for effect modification.

TABLE 5. Stratified analyses of maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood, by parental history of mental illness

Unadjusted AnalysisAdjusted Analysis
Exposure Type and Parental History of Mental IllnessOffspring Psychosis (N)Odds Ratio95% CIpOdds Ratio95% CIp
Any bacterial infection
 Present132.51.2–5.30.732.3a1.1–5.00.42
 Not present291.71.1–2.71.6a1.0–2.6
Localized bacterial infection
 Present112.11.0–4.60.412.0a0.9–4.50.41
 Not present241.40.9–2.31.4a0.9–2.2
Multisystemic bacterial infection
 Present44.5b1.5–13.40.634.6b,c1.5–13.80.58
 Not present52.4b1.0–6.02.4b,c1.0–5.9

aOdds ratios were adjusted for maternal education, socioeconomic index, maternal race/ethnicity, study site, season and year of birth, offspring sex, participation in the final follow-up of the Collaborative Perinatal Project study, maternal neurological or psychiatric conditions during pregnancy, and viral infection during pregnancy, through multivariate logistic regression models.

bWe fitted exact logistic regression for multisystemic bacterial infection and estimated exact p values.

cOdds ratios and confidence intervals were adjusted for viral infection during pregnancy, offspring sex, and maternal race/ethnicity.

TABLE 5. Stratified analyses of maternal bacterial infection during pregnancy and offspring risk for schizophrenia and related psychoses in adulthood, by parental history of mental illness

Enlarge table

Sensitivity Analyses

Of the 3,499 reported instances of bacterial infection, 1,785 (51%) were confirmed by a record of treatment with antibiotics and/or medical diagnosis. Of the 399 reported instances of multisystemic bacterial infection, 357 (89%) were confirmed. Of the 3,191 instances of localized bacterial infection, 1,513 (47%) were confirmed. Using the confirmed instances of bacterial infection, we were able to replicate the same patterns of associations from the main analyses. As expected, the magnitude of the hypothesized associations was slightly increased in the sensitivity analyses—potentially because of the reduction of nondifferential misclassification of exposure (see Tables S1–S3 in the online supplement).

Discussion

Maternal bacterial infection during pregnancy was significantly associated with subsequent development of schizophrenia and related psychoses among offspring. Localized bacterial infection predicted a 1.6-fold increase in the odds of developing a psychotic disorder in adulthood, and multisystemic bacterial infection predicted a nearly threefold increase in the odds. Furthermore, maternal bacterial infection was more strongly associated with the likelihood of developing psychosis among male than female offspring, and this effect modification was statistically significant for any bacterial infection (p=0.018) and approached significance for localized bacterial infection (p=0.084). However, these findings must be interpreted with caution given the overlapping confidence intervals of the sex-specific estimates. In addition, we found no statistical evidence for the hypothesized effect modification by reported parental mental illness, possibly because our measure of parental mental illness is a limited indicator of genetic risk.

Our findings in this study underscore the potential role of maternal bacterial infection during pregnancy in the etiology of psychotic disorders. Maternal bacterial infection during pregnancy has been found to induce the production of cytokines by the maternal immune system, the placenta, or the fetus itself (32). Our group and others have found significant associations of prenatal levels of proinflammatory cytokines with the offspring’s risk of schizophrenia and related psychoses (11, 33, 34), which, in a direct test, differed by sex (11). Others have suggested that the effects of bacterial infection may not be specific to the prenatal period but that these findings implicate a generally increased familial susceptibility to infections, both during and outside pregnancy (35). Although we cannot test this hypothesis with the CPP data, future studies may examine the effects of bacterial infection occurring before, during, and after pregnancy and ascertain their temporal specificity in psychosis risk.

Sex Difference in Schizophrenia and Related Psychoses

Our findings suggest that maternal bacterial infection during pregnancy may differentially affect the development of schizophrenia and related psychoses, depending on offspring sex. This is consistent with the long history from our group (11, 36, 37) and others (38) investigating sex differences in psychoses and relating disease risk, course, and outcome. Some have suggested a role of the placenta, in that the placenta of female fetuses may possess a greater ability to adapt to fluctuating in utero environmental conditions (such as prenatal immune challenges) compared with that of male fetuses (39). However, the mechanisms underlying a male-specific vulnerability remain uncertain. Perhaps these effects could be due to reduced maternal-fetal compatibility for male fetuses, which may need to up-regulate immune-associated transcripts to resist an attack by the maternal immune system (40). In a study of healthy fetuses, males had higher levels of cytokines indicative of a Th1-type (i.e., proinflammatory) response and expression of genes involved in the immune system and inflammation (41). In contrast, females had higher levels of cytokines indicative of Th2-type (i.e., anti-inflammatory) response and expression of genes involved in immune regulation. On stimulation with bacterial endotoxin, levels of interleukin-1 and interleukin-6 were significantly higher in male than in female fetal blood samples (42), consistent with our previous findings in maternal sera related to psychosis risk in males (11). Given that these proinflammatory cytokines have long been implicated in schizophrenia and related psychoses, these findings further elucidate a potential pathway explaining male vulnerability to psychotic disorders with regard to maternal bacterial infection during pregnancy.

Strengths and Limitations

The major strength of this study is that reports of bacterial infection were obtained during pregnancy, and clinical diagnoses of schizophrenia and related psychoses among offspring were systematically gathered on the basis of chart diagnoses and in-person structured interviews with participants, allowing us to investigate prospective relationships between maternal bacterial infection during pregnancy and the offspring’s risk of psychotic disorders.

Our study also had some limitations. The first limitation is related to our case identification procedures and the resulting case series. The 116 case subjects (0.7% of the cohort) may not include all instances of schizophrenia and related psychoses in this cohort. In fact, our group was primarily seeking to enroll the most severe cases of psychotic disorders, and the anticipated prevalence of this subset of disorders was 2.4% (43). In the study design phase, we excluded those who had organic or substance-induced psychosis to minimize false positive cases of psychotic disorders. In the analytic phase, we adjusted all statistical models for the effect of participation in the final follow-up assessment of the larger CPP study at offspring age 7—which was a strong predictor of being identified as a psychotic case subject in adulthood. Based on our previous examination of study participants, we conclude that this likely has an impact on the study’s statistical power, but we would not expect the completeness of ascertainment to differ in relation to prenatal infections. Owing to the limited power, we were not able to formally test effect modification for multisystemic bacterial infection and determine whether the findings are specific to schizophrenia, nonaffective psychosis, or other classes of psychosis.

Nevertheless, it is important to note that our subsample of case subjects identified through our record linkages with tertiary public hospitals tends to overrepresent persons with greater severity of conditions and lower socioeconomic status and to underrepresent high-functioning case subjects without hospitalization. In contrast, our subsample of case subjects identified through our direct follow-up and interview studies tends to overrepresent those with greater residential stability, levels of independent functioning, and socioeconomic status, as described in our earlier publication (44). Given our use of various methods of case ascertainment, we do not expect any extreme bias toward persons of higher or lower illness severity, as both poles of the psychosis severity spectrum may have been slightly overrepresented in this study. Based on our group’s previous analyses of the considerable amount of information available from this longitudinal study (12), it does not seem that the ascertained case subjects differ considerably from expectations, for instance, in terms of gender distribution, socioeconomic level, or family history of mental illness.

Another limitation pertains to the potential misclassification of exposure. Most previous studies have determined maternal bacterial infection during pregnancy on the basis of maternal self-reports or clinical records (24). Similarly, we used clinical records as the primary source of exposure information. Since the most prevalent types of bacterial infection are often asymptomatic, it is likely that some occurrences were not recorded and that only the more severe instances were included (8). Several population-based studies have employed antibiotic use as a proxy of bacterial infection (45). They demonstrated that a focus on antibiotic prescription and utilization allows for an ascertainment of a wide range of bacterial infections with different severity and potentially reduces false negatives. Inspired by this approach, we identified a subset of reported instances of bacterial infection that had corresponding medical diagnoses and/or a history of treatment with antibacterial medications and conducted sensitivity analyses. Possibly because of the reduction of nondifferential misclassification of exposure, the estimated effects of prenatal bacterial infection from the sensitivity analyses were slightly greater in magnitude than those from the main analyses.

Lastly, it is essential to note the possibility of other mechanisms that may interact with the biological mechanism examined in this study. In our analytic sample, prenatal bacterial infection was associated with several socioeconomic covariates, highlighting the importance of social factors in determining the occurrence of exposure. In fact, our group has previously reported that socioeconomic disadvantages during pregnancy—measured by parental education, income, occupation, and family structure—may significantly increase the risk for neurological abnormalities in offspring (46). In a subsequent study, we reported that this association could be partially explained by socioeconomically driven variations in gestational immune activity, which was quantified using archived maternal sera collected during pregnancy (47). In future studies, we may investigate the joint contribution of bacterial infection and socioeconomic disadvantage during pregnancy and potentially delineate a more comprehensive etiologic mechanism for schizophrenia and related psychoses.

Conclusions

There is considerable evidence that gestational viral infections during pregnancy have adverse consequences in offspring (1). Our findings were consistent with this and extended previous work by demonstrating a significant impact of maternal bacterial infection during pregnancy on later risk for schizophrenia and related psychoses, which was particularly dependent on the severity of infection and offspring sex. These findings could be an important first step to motivating large-scale national register-based investigation of this type of research question. Larger samples would provide opportunities to address some of the crucial components on the etiologic pathway from prenatal bacterial infection to psychosis, such as gestational timing of exposure, sex-specific transmission of psychotic illness, specific subtypes of psychosis, and finer categorization of infectious exposure. If replicated, our findings would also call for public health and clinical efforts that focus on preventing and managing bacterial infection in pregnant women. It is crucial to evaluate both short- and long-term consequences associated with different types of bacterial infection and antibacterial medication to avoid untoward effects on the mother and fetus (15, 48).

Department of Epidemiology, Brown University, Providence, R.I. (Lee, Savitz, Buka); Department of Pediatric Newborn Medicine, Brigham and Women’s Hospital, Boston (Cherkerzian); Department of Medicine, Harvard Medical School, Boston (Cherkerzian, Goldstein); Division of Public Psychiatry, Massachusetts Mental Health Center, Beth Israel Deaconess Medical Center, Boston (Seidman); Department of Psychiatry, Massachusetts General Hospital, Boston (Seidman, Goldstein); Department of Psychiatry, Harvard Medical School, Boston (Seidman, Goldstein); Division of Women’s Health, Department of Medicine, Brigham and Women’s Hospital, Boston (Goldstein); Center for Statistical Sciences, Brown University, Providence, R.I. (Papandonatos); and Department of Psychiatry, University of California San Diego, La Jolla (Tsuang).
Address correspondence to Dr. Buka ().

Presented at the 108th annual meeting of the American Psychopathological Association, New York, March 1–3, 2018.

Dr. Seidman died in September 2017.

Supported by grants from the Stanley Medical Research Institute (Drs. Buka and Goldstein, 1994–1997), NIMH grants R01 MH56956 (Dr. Goldstein, principal investigator) and R01 MH63951 (Dr. Seidman, principal investigator).

Dr. Goldstein has served as a consultant for Cala Health. The other authors report no financial relationships with commercial interests.

The authors thank Monica Landi, M.S.W., and June Wolf, Ph.D., for their contributions to clinical interviewing and diagnoses, respectively, and Christiana Provencal for her contribution to project management during the original sample acquisition.

References

1 Brown AS, Derkits EJ: Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010; 167:261–280LinkGoogle Scholar

2 Sørensen HJ, Mortensen EL, Reinisch JM, et al.: Association between prenatal exposure to bacterial infection and risk of schizophrenia. Schizophr Bull 2009; 35:631–637Crossref, MedlineGoogle Scholar

3 Babulas V, Factor-Litvak P, Goetz R, et al.: Prenatal exposure to maternal genital and reproductive infections and adult schizophrenia. Am J Psychiatry 2006; 163:927–929LinkGoogle Scholar

4 Brown AS, Schaefer CA, Wyatt RJ, et al.: Maternal exposure to respiratory infections and adult schizophrenia spectrum disorders: a prospective birth cohort study. Schizophr Bull 2000; 26:287–295Crossref, MedlineGoogle Scholar

5 Mikhail MS, Anyaegbunam A: Lower urinary tract dysfunction in pregnancy: a review. Obstet Gynecol Surv 1995; 50:675–683Crossref, MedlineGoogle Scholar

6 Mazor-Dray E, Levy A, Schlaeffer F, et al.: Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome? J Matern Fetal Neonatal Med 2009; 22:124–128Crossref, MedlineGoogle Scholar

7 Farkash E, Weintraub AY, Sergienko R, et al.: Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes. Eur J Obstet Gynecol Reprod Biol 2012; 162:24–27Crossref, MedlineGoogle Scholar

8 McDermott S, Callaghan W, Szwejbka L, et al.: Urinary tract infections during pregnancy and mental retardation and developmental delay. Obstet Gynecol 2000; 96:113–119MedlineGoogle Scholar

9 Camp BW, Broman SH, Nichols PL, et al.: Maternal and neonatal risk factors for mental retardation: defining the “at-risk” child. Early Hum Dev 1998; 50:159–173Crossref, MedlineGoogle Scholar

10 Clarke MC, Tanskanen A, Huttunen M, et al.: Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 2009; 166:1025–1030LinkGoogle Scholar

11 Goldstein JM, Buka SL, Seidman LJ, et al.: Specificity of familial transmission of schizophrenia psychosis spectrum and affective psychoses in the New England Family Study’s high-risk design. Arch Gen Psychiatry 2010; 67:458–467Crossref, MedlineGoogle Scholar

12 Goldstein JM, Cherkerzian S, Seidman LJ, et al.: Prenatal maternal immune disruption and sex-dependent risk for psychoses. Psychol Med 2014; 44:3249–3261Crossref, MedlineGoogle Scholar

13 Meyer U, Feldon J: Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 2010; 90:285–326Crossref, MedlineGoogle Scholar

14 Boksa P: Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010; 24:881–897Crossref, MedlineGoogle Scholar

15 Humann J, Mann B, Gao G, et al.: Bacterial peptidoglycan traverses the placenta to induce fetal neuroproliferation and aberrant postnatal behavior. Cell Host Microbe 2016; 19:388–399Crossref, MedlineGoogle Scholar

16 McCarthy MM: Sex differences in neuroimmunity as an inherent risk factor. Neuropsychopharmacology 2018; 44:38–44Crossref, MedlineGoogle Scholar

17 Goldstein JM, Seidman LJ, O’Brien LM, et al.: Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Arch Gen Psychiatry 2002; 59:154–164Crossref, MedlineGoogle Scholar

18 Goldstein JM, Walder DJ: Sex differences in schizophrenia: the case for developmental origins, in The Early Course of Schizophrenia. Edited by Sharma T, Harvey PJ. New York, Oxford University Press, 2006, pp 143–173Google Scholar

19 Sullivan PF, Kendler KS, Neale MC: Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 2003; 60:1187–1192Crossref, MedlineGoogle Scholar

20 Dean K, Stevens H, Mortensen PB, et al.: Full spectrum of psychiatric outcomes among offspring with parental history of mental disorder. Arch Gen Psychiatry 2010; 67:822–829Crossref, MedlineGoogle Scholar

21 van Os J, Rutten BPF, Poulton R: Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull 2008; 34:1066–1082Crossref, MedlineGoogle Scholar

22 Niswander KR, Gordon M: The Women and Their Pregnancies: The Collaborative Perinatal Study of the National Institute of Neurological Diseases and Stroke. Washington, DC, US Department of Health, Education, and Welfare, 1972Google Scholar

23 Goldstein JM, Seidman LJ, Buka SL, et al.: Impact of genetic vulnerability and hypoxia on overall intelligence by age 7 in offspring at high risk for schizophrenia compared with affective psychoses. Schizophr Bull 2000; 26:323–334Crossref, MedlineGoogle Scholar

24 Seidman LJ, Buka SL, Goldstein JM, et al.: The relationship of prenatal and perinatal complications to cognitive functioning at age 7 in the New England Cohorts of the National Collaborative Perinatal Project. Schizophr Bull 2000; 26:309–321Crossref, MedlineGoogle Scholar

25 Seidman LJ, Giuliano AJ, Smith CW, et al.: Neuropsychological functioning in adolescents and young adults at genetic risk for schizophrenia and affective psychoses: results from the Harvard and Hillside Adolescent High Risk Studies. Schizophr Bull 2006; 32:507–524Crossref, MedlineGoogle Scholar

26 Seidman LJ, Buka SL, Goldstein JM, et al.: Intellectual decline in schizophrenia: evidence from a prospective birth cohort 28 year follow-up study. J Clin Exp Neuropsychol 2006; 28:225–242Crossref, MedlineGoogle Scholar

27 First MB, Spitzer RL, Gibbon M, et al.: Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition, Version 2. Washington, DC, American Psychiatric Press, 1996Google Scholar

28 American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, 4th ed (DSM-IV). Washington, DC, American Psychiatric Association, 1994Google Scholar

29 Myrianthopoulos NC, French KS: An application of the US Bureau of the Census socioeconomic index to a large, diversified patient population. Soc Sci Med 1968; 2:283–299Crossref, MedlineGoogle Scholar

30 Krause D, Matz J, Weidinger E, et al.: The association of infectious agents and schizophrenia. World J Biol Psychiatry 2010; 11:739–743Crossref, MedlineGoogle Scholar

31 Goldstein JM, Cherkerzian S, Seidman LJ, et al.: Sex-specific rates of transmission of psychosis in the New England high-risk family study. Schizophr Res 2011; 128:150–155Crossref, MedlineGoogle Scholar

32 Urakubo A, Jarskog LF, Lieberman JA, et al.: Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain. Schizophr Res 2001; 47:27–36Crossref, MedlineGoogle Scholar

33 Brown AS, Hooton J, Schaefer CA, et al.: Elevated maternal interleukin-8 levels and risk of schizophrenia in adult offspring. Am J Psychiatry 2004; 161:889–895LinkGoogle Scholar

34 Buka SL, Tsuang MT, Torrey EF, et al.: Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 2001; 15:411–420Crossref, MedlineGoogle Scholar

35 Nielsen PR, Laursen TM, Mortensen PB: Association between parental hospital-treated infection and the risk of schizophrenia in adolescence and early adulthood. Schizophr Bull 2013; 39:230–237Crossref, MedlineGoogle Scholar

36 Goldstein JM, Cherkerzian S, Tsuang MT, et al.: Sex differences in the genetic risk for schizophrenia: history of the evidence for sex-specific and sex-dependent effects. Am J Med Genet B Neuropsychiatr Genet 2013; 162B:698–710Crossref, MedlineGoogle Scholar

37 Abel KM, Drake R, Goldstein JM: Sex differences in schizophrenia. Int Rev Psychiatry 2010; 22:417–428Crossref, MedlineGoogle Scholar

38 Ochoa S, Usall J, Cobo J, et al.: Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review. Schizophr Res Treatment 2012; 2012:916198Crossref, MedlineGoogle Scholar

39 Rosenfeld CS: Sex-specific placental responses in fetal development. Endocrinology 2015; 156:3422–3434Crossref, MedlineGoogle Scholar

40 Cvitic S, Longtine MS, Hackl H, et al.: The human placental sexome differs between trophoblast epithelium and villous vessel endothelium. PLoS One 2013; 8:e79233Crossref, MedlineGoogle Scholar

41 Enninga EA, Nevala WK, Creedon DJ, et al.: Fetal sex-based differences in maternal hormones, angiogenic factors, and immune mediators during pregnancy and the postpartum period. Am J Reprod Immunol 2015; 73:251–262Crossref, MedlineGoogle Scholar

42 Kim-Fine S, Regnault TRH, Lee JS, et al.: Male gender promotes an increased inflammatory response to lipopolysaccharide in umbilical vein blood. J Matern Fetal Neonatal Med 2012; 25:2470–2474Crossref, MedlineGoogle Scholar

43 Perälä J, Suvisaari J, Saarni SI, et al.: Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry 2007; 64:19–28Crossref, MedlineGoogle Scholar

44 Seidman LJ, Cherkerzian S, Goldstein JM, et al.: Neuropsychological performance and family history in children at age 7 who develop adult schizophrenia or bipolar psychosis in the New England Family Studies. Psychol Med 2013; 43:119–131Crossref, MedlineGoogle Scholar

45 Köhler O, Petersen L, Mors O, et al.: Infections and exposure to anti-infective agents and the risk of severe mental disorders: a nationwide study. Acta Psychiatr Scand 2017; 135:97–105Crossref, MedlineGoogle Scholar

46 Hung GCL, Pietras SA, Carliner H, et al.: Cognitive ability in childhood and the chronicity and suicidality of depression. Br J Psychiatry 2016; 208:120–127Crossref, MedlineGoogle Scholar

47 Gilman SE, Hornig M, Ghassabian A, et al.: Socioeconomic disadvantage, gestational immune activity, and neurodevelopment in early childhood. Proc Natl Acad Sci USA 2017; 114:6728–6733MedlineGoogle Scholar

48 Köhler-Forsberg O, Petersen L, Gasse C, et al.: A nationwide study in Denmark of the association between treated infections and the subsequent risk of treated mental disorders in children and adolescents. JAMA Psychiatry 2018; 76:271–279CrossrefGoogle Scholar